Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Thomas M. who wrote (1112)	9/2/1998 12:31:00 AM
From: Bob Swift	Read Replies (1) \| Respond to of 10280

For long term investors, as long as there is no margin call, it hardly matters what price SEPR is at short term. The launch of levalbuterol will push SEPR up before the end of this year. My goal is to accumulate as many shares as possible before it gets to be too high for my limited amount of capital. I am not that good at guessing if DOW will or will not hit 6000 but I do think that SEPR will go up as time progresses and there may not be a chance to get in at this level in the future. Up to now, I have bought a total of 20 times over the past couple of years, including the time when it dropped from 25 to 19 1/4. It always look scary and expensive at the time but it pays off in the long run. Besides, if the DOW drops to 6000, what kind of stocks will investors flock to ? Drug companies !